Arterial Blood Gas Kits Market Report By Insights, Size, and Growth - 2031

The market for healthcare manikins is projected to expand from US$ 712.46 million in 2023 to US$ 1,298.03 million by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% during the period from 2023 to 2031.

Several key segments have been identified in the analysis of the arterial blood gas kits market, including syringe type, usage, type, needle gauge, syringe volume, application, and end user.

In terms of syringe type, the market is divided into adult Luer slip syringes and Luer lock syringes. The Luer lock syringe segment dominated the market share in 2023. Luer lock syringes are characterized by a standardized, threaded tip known as a Luer lock. A significant benefit of these syringes is their capacity to create a secure, leak-proof connection, which minimizes the risk of contamination. The twist-lock mechanism inherent in the design prevents accidental disconnection, ensuring safety for both patients and healthcare providers during procedures. Additionally, Luer lock syringes are versatile and compatible with a variety of medical devices. The widespread adoption of standardized Luer lock fittings in healthcare facilitates the interchangeability of components without the need for specialized connectors. This interoperability enables healthcare professionals to select and connect the necessary accessories tailored to individual patient requirements, thereby enhancing treatment efficiency and effectiveness.

The market is also categorized by type into vented and non-vented syringes, with the vented segment holding a larger market share in 2023.

When considering usage, the market is divided into pre-set plunger mode and manual aspiration, with the pre-set plunger mode segment leading in market share in 2023. Pre-set syringes are designed for single-use sterile blood collection and come equipped with needles specifically for collecting, containing, and preserving blood specimens for in-vitro testing. These devices feature a user-activated safety shield to mitigate the risk of accidental needle stick injuries. The pre-set plunger mode allows healthcare professionals to determine the precise volume of blood needed for tests, ensuring consistent and accurate sample collection while minimizing errors or variability in the required blood volume. This pre-setting capability also reduces the time spent on manual adjustments, enhancing usability and contributing to patient comfort. Overall, the pre-set plunger mode significantly improves accuracy, efficiency, and safety during arterial blood gas sampling procedures.

In terms of application, the market is segmented into in vitro diagnostics and electrolyte analysis, with the in vitro diagnostics segment further divided into pH blood gas, oxygen content, and other categories. The in vitro diagnostics segment captured a larger market share in 2023. Arterial blood gas kits designed for in vitro testing are essential for measuring and analyzing electrolyte levels, pH, partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), bicarbonate (HCO3-), and base excess (BE) from arterial blood samples. This analysis is crucial for healthcare professionals to evaluate a patient?s acid-base balance, oxygenation, and overall respiratory function. According to the National Committee for Clinical Laboratory Standards (NCCLS), arterial blood gas analysis is more impactful on patient care than any other laboratory test. Rapid results are often necessary for managing chronic conditions such as chronic lung diseases, respiratory failure, chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and metabolic disorders. The analysis of arterial blood gases provides timely test results and aids in ventilator management, guiding treatment plans effectively. Furthermore, pH analysis is a vital in vitro test for monitoring patients' acid-base balance and gas exchange efficiency in clinical environments. Kits that measure pH provide healthcare professionals with real-time insights into a patient?s respiratory and metabolic status. The pH level indicates the hydrogen ion concentration in the blood, which is essential for assessing acid-base imbalances due to acidosis or alkalosis stemming from respiratory or metabolic issues. By utilizing an arterial blood gas kit for pH analysis, healthcare providers can swiftly ascertain whether a patient?s blood pH falls within the normal range (7.35-7.45). Deviations from this range can yield critical diagnostic information, such as identifying respiratory acidosis through low pH levels. This capability allows for prompt diagnosis and management of respiratory and metabolic disorders, ensuring optimal patient care in critical and emergency settings. Leading manufacturers are actively developing innovative products for in vitro diagnostics, including Pulset Arterial Blood Gas Complete Kits by AirLife, ICU Medical Pro-Vent Plus Arterial Blood Gas Sampling Kits by Thermo Fisher Scientific Inc, and BD Preset Eclipse Arterial Blood Collection Syringes.

The market is also segmented by needle gauge into 23G, 23G to 25G, and greater than 25G, with the 23G to 25G segment holding the largest market share in 2023.

Regarding syringe volume, the market is categorized into 1 ml, 3 ml, and other sizes, with the 3 ml segment leading in market share in 2023.

Finally, the market is segmented by end user into hospitals and clinics, diagnostic laboratories, and others, with hospitals and clinics dominating the market in 2023.

The healthcare manikins market report encompasses regions including North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the global healthcare manikins market, while the Asia Pacific region is expected to exhibit the highest CAGR from 2023 to 2031. The arterial blood gas kits market in Asia Pacific is further segmented into China, Japan, India, Australia, South Korea, Kazakhstan, and the Rest of Asia Pacific. Factors such as an increasing elderly population, rising chronic diseases, advancements in technology, and a growing number of startups are propelling market growth in this region. In India, respiratory diseases significantly impact the quality of life, and heightened awareness of conditions like asthma, COPD, and respiratory syndrome presents substantial growth opportunities for the arterial blood gas kits market. Respiratory distress syndrome (RDS) is prevalent among premature infants in India, leading to approximately 150,000 deaths annually. The Global Burden of Disease (GBD) report indicates that chronic obstructive pulmonary disease (COPD) ranks as the second leading cause of death and disability-adjusted life years (DALYs) in India. According to data from the Lancet Global Health in April 2020, around 300 million individuals globally are affected by asthma, with 37.9 million of them residing in India.

Statistics from the Government of India reveal a significant demographic shift over the past 50 years, with the elderly population aged 60 and above nearly tripling. A BQ Prime article notes that approximately 138 million individuals in India were aged 60 years and older in 2021, a figure projected to reach 194 million by 2031. By 2050, India?s elderly population is expected to surpass the number of children under 14 years. Aging is a significant predictor of acute respiratory diseases, particularly among critically ill older adults.

Key primary and secondary sources utilized in preparing the report on the healthcare manikins market include the European Union (EU), the Organisation for Economic Co-operation and Development (OECD), and the National Library of Medicine (NLM).